Analysis of TSC1 truncations defines regions involved in TSC1 stability, aggregation and interaction

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1802, Issue 9, 2010, Pages 774-781

  Hoogeveen Westerveld, Marianne ^a   Exalto, Carla ^a   Maat Kievit, Anneke ^a   van den Ouweland, Ans ^a   Halley, Dicky ^a   Nellist, Mark ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

TORC1; TSC1; TSC2; Tuberous sclerosis complex

Indexed keywords

GENE PRODUCT; TARGET OF RAPAMYCIN COMPLEX 1; TARGET OF RAPAMYCIN KINASE; UNCLASSIFIED DRUG;

ARTICLE; EMBRYO; GENE FUNCTION; GENE STRUCTURE; HAMARTOMA; HUMAN; HUMAN CELL; MUTATION; PRIORITY JOURNAL; PROTEIN AGGREGATION; PROTEIN INTERACTION; PROTEIN STABILITY; TUBEROUS SCLEROSIS; TUBEROUS SCLEROSIS COMPLEX 1 GENE; TUBEROUS SCLEROSIS COMPLEX 2 GENE;

EID: 77954959759     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bbadis.2010.06.004     Document Type: Article

References (24)

1. The Tuberous Sclerosis Complex 1999, Oxford University Press, Oxford, UK. M. Gomez, J. Sampson, V. Whittemore (Eds.).
2. van Slegtenhorst M., de Hoogt R., Hermans C., Nellist M., Janssen L.A.J., Verhoef S., Lindhout D., van den Ouweland A.M.W., Halley D.J.J., Young J., Burley M., Jeremiah S., Woodward K., Nahmias J., Fox M., Ekong R., Wolfe J., Povey S., Osborne J., Snell R.G., Cheadle J.P., Jones A.C., Tachataki M., Ravine D., Sampson J.R., Reeve M.P., Richardson P., Wilmer F., Munro C., Hawkins T.L., Sepp T., Ali J.B.M., Ward S., Green A.J., Yates J.R.W., Short M.P., Haines J.H., Jozwiak S., Kwiatkowska J., Henske E.P., Kwiatkowski D.J. Identification of the tuberous sclerosis gene TSC1 on chromosome 9q34. Science 1997, 277:805-808.
3. The European Chromosome 16 Tuberous Sclerosis Consortium Identification and characterization of the tuberous sclerosis gene on chromosome 16. Cell 1993, 75:1305-1315.
4. van Slegtenhorst M., Nellist M., Nagelkerken B., Cheadle J., Snell R., van den Ouweland A., Reuser A., Sampson J.R., Halley D., van der Sluijs P. Interaction between hamartin and tuberin, the TSC1 and TSC2 gene products. Hum. Mol. Genet. 1998, 7:1053-1057.
5. Li Y., Corradetti M.N., Inoki K., Guan K.-L. TSC2: filling the GAP in the mTOR signaling pathway. Trends Biochem. Sci. 2003, 28:573-576.
6. Guertin D.A., Sabatini D.M. Defining the role of mTOR in cancer. Cancer Cell 2007, 12:9-22.
7. Zhang Y., Gao X., Saucedo L.J., Ru B., Edgar B.A., Pan D. Rheb is a direct target of the tuberous sclerosis tumour suppressor proteins. Nat. Cell Biol. 2003, 5:578-581.
8. Garami A., Zwartkruis F.J., Nobukuni T., Joaquin M., Roccio M., Stocker H., Kozma S.C., Hafen E., Bos J.L., Thomas G. Insulin activation of Rheb, a mediator of mTOR/S6K/4E-BP signaling, is inhibited by TSC1 and 2. Mol. Cell 2003, 11:1457-1466.
9. Tee A.R., Manning B.D., Roux P.P., Cantley L.C., Blenis J. Tuberous sclerosis complex gene products, tuberin and hamartin, control mTOR signaling by acting as a GTPase-activating protein complex toward Rheb. Curr. Biol. 2003, 13:1259-1268.
10. Castro A.F., Rebhun J.F., Clark G.J., Quilliam L.A. Rheb binds tuberous sclerosis complex 2 (TSC2) and promotes S6 kinase activation in a rapamycin- and farnesylation-dependent manner. J. Biol. Chem. 2003, 278:32493-32496.
11. Inoki K., Li Y., Xu T., Guan K.-L. Rheb GTPase is a direct target of TSC2 GAP activity and regulates mTOR signaling. Genes Dev. 2003, 17:1829-1834.
12. Cai S.L., Tee A.R., Short J.D., Bergeron J.M., Kim J., Shen J., Guo R., Johnson C.L., Kiguchi K., Walker C.L. Activity of TSC2 is inhibited by AKT-mediated phosphorylation and membrane partitioning. J. Cell Biol. 2006, 173:279-289.
13. Rosner M., Hanneder M., Siegel N., Valli N., Hengstschlager M. The tuberous sclerosis gene products hamartin and tuberin are multifunctional proteins with a wide spectrum of interacting partners. Mutat. Res. 2008, 658:234-246.
14. Nellist M., van Slegtenhorst M.A., Goedbloed M., van den Ouweland A.M.W., Halley D.J.J., van der Sluijs P. Characterization of the cytosolic tuberin-hamartin complex: tuberin is a cytosolic chaperone for hamartin. J. Biol. Chem. 1999, 274:35647-35652.
15. Nellist M., Verhaaf B., Goedbloed M.A., Reuser A.J.J., van den Ouweland A.M.W., Halley D.J.J. TSC2 missense mutations inhibit tuberin phosphorylation and prevent formation of the tuberin-hamartin complex. Hum. Mol. Genet. 2001, 10:2889-2898.
16. Mozaffari M., Hoogeveen-Westerveld M., Kwiatkowski D., Sampson J., Ekong R., Povey S., den Dunnen J.T., van den Ouweland A., Halley D., Nellist M. Identification of a region required for TSC1 stability by functional analysis of TSC1 missense mutations found in individuals with tuberous sclerosis complex. BMC Med. Genet. 2009, 10:e88.
17. Nellist M., van den Heuvel D., Schluep D., Exalto C., Goedbloed M., Maat-Kievit A., van Essen T., van Spaendonck-Zwarts K., Jansen F., Helderman P., Bartalini G., Vierimaa O., Penttinen M., van den Ende J., van den Ouweland A., Halley D. Missense mutations to the TSC1 gene cause tuberous sclerosis complex. Eur. J. Hum. Genet. 2009, 17:319-328.
18. Nellist M., Sancak O., Goedbloed M.A., Rohe C., van Netten D., Mayer K., Tucker-Williams A., van den Ouweland A.M.W., Halley D.J.J. Distinct effects of single amino acid changes to tuberin on the function of the tuberin-hamartin complex. Eur. J. Hum. Genet. 2005, 13:59-68.
19. Coevoets R., Arican S., Hoogeveen-Westerveld M., Simons E., van den Ouweland A., Halley D., Nellist M. A reliable cell-based assay for testing unclassified TSC2 gene variants. Eur. J. Hum. Genet. 2009, 17:301-310.
20. Sancak O., Nellist M., Goedbloed M., Elfferich P., Wouters C., Maat-Kievit A., Zonnenberg B., Verhoef S., Halley D., van den Ouweland A. Mutational analysis of the TSC1 and TSC2 genes in a diagnostic setting: genotype-phenotype correlations and comparison of diagnostic DNA techniques in tuberous sclerosis complex. Eur. J. Hum. Genet. 2005, 13:731-741.
21. Tuberous sclerosis database - Leiden Open Variation Database []. http://www.chromium.liacs.nl/lovd/index.php?select_db=TSC1.
22. Pymar L.S., Platt F.M., Askham J.M., Morrison E.E., Knowles M.A. Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms. Hum. Mol. Genet. 2008, 17:2006-2017.
23. Inoki K., Guan K.-L. Tuberous sclerosis complex, implication from a rare genetic disease to common cancer treatment. Hum. Mol. Genet. 2009, 18:94-100.
24. de Vries P., Howe C.J. The tuberous sclerosis complex proteins - a GRIPP on cognition and neurodevelopment. Trends Mol. Med. 2007, 13:319-326.